One of the unresolved problems on the way to improving the pharmacotherapy of CNS diseases is the development and creation of technologies that allow drugs to cross the blood-brain barrier (BBB). The review discusses modern methods of drug delivery to the CNS. The advantages and disadvantages of the main pharmacological strategies for directly overcoming the BBB and an alternative to this are shown. New methods of drug delivery to the brain with damage (physical, chemical, etc.) and without disruption of the blood-brain barrier structure (small molecules, cell-mediated transport, stem cells) are considered. The prospects for the use of artificial nanosized drug transporters are discussed. An alternative strategy of pharmacological action on the CNS structures (intranasal route) is shown to be promising. Possible mechanisms of action of pharmacological agents on CNS structures bypassing the BBB are considered.
Molecular mechanisms of transport of substances across the blood-brain barrier as targets for pharmacological action Part 2. Modern methods of delivery of pharmacological agents to the central nervous system
M. Litvinova,A. Trofimov,P. Shabanov,A. Lebedev,E. Bychkov,Nikolay А. Arseniev,A. Tyukavin
Published 2023 in Pharmacy Formulas
ABSTRACT
PUBLICATION RECORD
- Publication year
2023
- Venue
Pharmacy Formulas
- Publication date
2023-01-10
- Fields of study
Not labeled
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-30 of 30 references · Page 1 of 1
CITED BY
Showing 1-4 of 4 citing papers · Page 1 of 1